HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NTP DEA review

This article was originally published in The Rose Sheet

Executive Summary

National Toxicology Program will evaluate diethanalomine for listing in the 11th Report on Carcinogens at an NTP Board of Scientific Counselors RoC Subcommittee meeting Nov. 19-20 in Bethesda, Md. DEA is among 10 chemicals scheduled for peer review, and NTP will provide opportunity for public comment on each of the substances during the meeting, agency notes. DEA, an ingredient widely used in personal care products, was nominated for listing in 2001 (1"The Rose Sheet" July 30, 2001, In Brief). NTP released a draft background document on DEA earlier this year (2"The Rose Sheet" June 3, 2002, p. 4)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS010620

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel